Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | GAA | P10253 | 4/20 | 0.67 |
| ▸ | RAD52 | P43351 | 2/20 | 0.67 |
| ▸ | GFER | P55789 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.66 |
| ▸ | DRD4 | P21917 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.54 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.53 |
| ▸ | DRD5 | P21918 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17144502 | 0.93 | KMT2A (0.63) | KMT2AKDM4EMAPTGAARAD52 | |
| SCHEMBL13079491 | 0.86 | KDM4E (0.78) | KMT2AKDM4EMAPTGAADRD4 | |
| SCHEMBL3769471 | 0.83 | SMN1; SMN2 (0.77) | KMT2AMAPTGFERSMN1; SMN2DRD4 | |
| SCHEMBL870704 | 0.82 | HTR3E (0.70) | KMT2AKDM4EMAPTGAAGFER | |
| SCHEMBL29998630 | 0.82 | HTR3E (0.70) | KMT2AKDM4EMAPTGAAGFER | |
| SCHEMBL29715804 | 0.82 | KDM4E (0.71) | KMT2AKDM4EMAPTGAADRD4 | |
| SCHEMBL14459608 | 0.82 | KDM4E (0.88) | KDM4EGAADRD4DRD5 | |
| SCHEMBL81930 | 0.82 | GAA (0.69) | KMT2AKDM4EMAPTGAARAD52 | |
| SCHEMBL10169299 | 0.81 | MAPT (0.68) | KMT2AKDM4EMAPTGAARAD52 | |
| SCHEMBL16676579 | 0.80 | KDM4E (0.97) | KDM4EGAADRD4LMNADRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765447-B1 | TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS | KEZAR LIFE SCIENCES (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20210332046-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-10-28 | — | — | US | disclosed |
| US-11155551-B2 | Nicotinic acetylcholine receptor silent agonists | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200247804-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2020-08-06 | — | — | US | disclosed |
| US-10662191-B2 | Nicotinic acetylcholine receptor silent agonists | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. (US) | 2020-05-26 | — | — | US | disclosed |
| US-20180298002-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2018-10-18 | — | — | US | disclosed |
| EP-3331864-A2 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Chong Kun Dang Pharmaceutical Corp. (KR) | 2018-06-13 | — | — | EP | disclosed |
| WO-2017083242-A1 | INHIBITORS OF SUPPRESSION OF TUMORIGENCITY 2 (ST2) AND METHODS USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-05-18 | — | — | WO | disclosed |
| WO-2017066558-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| US-20110105493-A1 | HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2011-05-05 | — | — | US | disclosed |
| US-4596891-A | PHENYL-N,N'-DIETHYLETHYLENE DIAMINES | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1986-06-24 | — | — | US | disclosed |
| US-4286983-A | INCLUDING COMPOUNDS OF THE N-PHENYL-N',N'-DIETHYL ALKYLENEDIAMINE TYPE | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1981-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180298002-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | CHRNA7, CHRNA2, CHRNE | KMT2A 1598/4885KDM4E 2070/4885MAPT 2570/4885 |
| US-11155551-B2 | Nicotinic acetylcholine receptor silent agonists | CHRNA7, CHRNA2, CHRNE | KMT2A 1598/4885KDM4E 2070/4885MAPT 2570/4885 |
| US-10662191-B2 | Nicotinic acetylcholine receptor silent agonists | CHRNA7, CHRNA2, CHRNE | KMT2A 1598/4885KDM4E 2070/4885MAPT 2570/4885 |
| US-20200247804-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | CHRNA7, CHRNA2, CHRNE | KMT2A 1598/4885KDM4E 2070/4885MAPT 2570/4885 |
| US-20210332046-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS | CHRNA7, CHRNA2, CHRNE | KMT2A 1598/4885KDM4E 2070/4885MAPT 2570/4885 |
| US-20110105493-A1 | HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS | ADORA2A, ADORA3, ADORA2B | KMT2A 1541/4885KDM4E 2230/4885MAPT 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.